Literature DB >> 31548232

Reassessing the Role of Histaminergic Tuberomammillary Neurons in Arousal Control.

Anne Venner1, Takatoshi Mochizuki2, Roberto De Luca1, Christelle Anaclet3, Thomas E Scammell1, Clifford B Saper1, Elda Arrigoni1, Patrick M Fuller4.   

Abstract

The histaminergic neurons of the tuberomammillary nucleus (TMNHDC) of the posterior hypothalamus have long been implicated in promoting arousal. More recently, a role for GABAergic signaling by the TMNHDC neurons in arousal control has been proposed. Here, we investigated the effects of selective chronic disruption of GABA synthesis (via genetic deletion of the GABA synthesis enzyme, glutamic acid decarboxylase 67) or GABAergic transmission (via genetic deletion of the vesicular GABA transporter (VGAT)) in the TMNHDC neurons on sleep-wake in male mice. We also examined the effects of acute chemogenetic activation and optogenetic inhibition of TMNHDC neurons upon arousal in male mice. Unexpectedly, we found that neither disruption of GABA synthesis nor GABAergic transmission altered hourly sleep-wake quantities, perhaps because very few TMNHDC neurons coexpressed VGAT. Acute chemogenetic activation of TMNHDC neurons did not increase arousal levels above baseline but did enhance vigilance when the mice were exposed to a behavioral cage change challenge. Similarly, acute optogenetic inhibition had little effect upon baseline levels of arousal. In conclusion, we could not identify a role for GABA release by TMNHDC neurons in arousal control. Further, if TMNHDC neurons do release GABA, the mechanism by which they do so remains unclear. Our findings support the view that TMNHDC neurons may be important for enhancing arousal under certain conditions, such as exposure to a novel environment, but play only a minor role in behavioral and EEG arousal under baseline conditions.SIGNIFICANCE STATEMENT The histaminergic neurons of the tuberomammillary nucleus of the hypothalamus (TMNHDC) have long been thought to promote arousal. Additionally, TMNHDC neurons may counter-regulate the wake-promoting effects of histamine through co-release of the inhibitory neurotransmitter, GABA. Here, we show that impairing GABA signaling from TMNHDC neurons does not impact sleep-wake amounts and that few TMNHDC neurons contain the vesicular GABA transporter, which is presumably required to release GABA. We further show that acute activation or inhibition of TMNHDC neurons has limited effects upon baseline arousal levels and that activation enhances vigilance during a behavioral challenge. Counter to general belief, our findings support the view that TMNHDC neurons are neither necessary nor sufficient for the initiation and maintenance of arousal under baseline conditions.
Copyright © 2019 the authors.

Entities:  

Keywords:  EEG/EMG; chemogenetics; histidine decarboxylase; optogenetics; sleep; wake

Mesh:

Substances:

Year:  2019        PMID: 31548232      PMCID: PMC6832676          DOI: 10.1523/JNEUROSCI.1032-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal.

Authors:  Rhannan H Williams; Melissa J S Chee; Daniel Kroeger; Loris L Ferrari; Eleftheria Maratos-Flier; Thomas E Scammell; Elda Arrigoni
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 2.  Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications.

Authors:  Andrew D Krystal; Elliott Richelson; Thomas Roth
Journal:  Sleep Med Rev       Date:  2013-01-26       Impact factor: 11.609

3.  Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.

Authors:  Zoltan Szakacs; Yves Dauvilliers; Vladimir Mikhaylov; Irina Poverennova; Sergei Krylov; Slavko Jankovic; Karel Sonka; Philippe Lehert; Isabelle Lecomte; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2017-01-25       Impact factor: 44.182

4.  Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice.

Authors:  Hu Zhu; Dipendra K Aryal; Reid H J Olsen; Daniel J Urban; Amanda Swearingen; Stacy Forbes; Bryan L Roth; Ute Hochgeschwender
Journal:  Genesis       Date:  2016-06-03       Impact factor: 2.487

5.  Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake.

Authors:  Carlos Blanco-Centurion; Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

6.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Authors:  Yves Dauvilliers; Claudio Bassetti; Gert Jan Lammers; Isabelle Arnulf; Geert Mayer; Andrea Rodenbeck; Philippe Lehert; Claire-Li Ding; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

7.  Amygdala lesions reduce cataplexy in orexin knock-out mice.

Authors:  Christian R Burgess; Yo Oishi; Takatoshi Mochizuki; John H Peever; Thomas E Scammell
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

8.  Transport of histamine by vesicular monoamine transporter-2.

Authors:  A Merickel; R H Edwards
Journal:  Neuropharmacology       Date:  1995-11       Impact factor: 5.250

Review 9.  Histamine: neural circuits and new medications.

Authors:  Thomas E Scammell; Alexander C Jackson; Nicholas P Franks; William Wisden; Yves Dauvilliers
Journal:  Sleep       Date:  2019-01-01       Impact factor: 5.849

10.  Characterization of gastric and neuronal histaminergic populations using a transgenic mouse model.

Authors:  Angela K Walker; Won-Mee Park; Jen-Chieh Chuang; Mario Perello; Ichiro Sakata; Sherri Osborne-Lawrence; Jeffrey M Zigman
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more
  14 in total

Review 1.  Role of the locus coeruleus and basal forebrain in arousal and attention.

Authors:  Eden B Maness; Joshua A Burk; James T McKenna; Felipe L Schiffino; Robert E Strecker; John G McCoy
Journal:  Brain Res Bull       Date:  2022-07-22       Impact factor: 3.715

Review 2.  A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.

Authors:  Gustavo Provensi; Alessia Costa; Barbara Rani; Patrizio Blandina; M Beatrice Passani
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 3.  Different Peas in the Same Pod: The Histaminergic Neuronal Heterogeneity.

Authors:  Gustavo Provensi; M Beatrice Passani; Patrizio Blandina
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Histamine as an Alert Signal in the Brain.

Authors:  Takatoshi Mochizuki
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 5.  The Role of the Central Histaminergic System in Behavioral State Control.

Authors:  Elda Arrigoni; Patrick M Fuller
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Sleep timing and the circadian clock in mammals: Past, present and the road ahead.

Authors:  Raymond E A Sanchez; Franck Kalume; Horacio O de la Iglesia
Journal:  Semin Cell Dev Biol       Date:  2021-06-04       Impact factor: 7.499

7.  Increased Sensitivity of Mice Lacking Extrasynaptic δ-Containing GABAA Receptors to Histamine Receptor 3 Antagonists.

Authors:  Shamsiiat Abdurakhmanova; Milo Grotell; Jenna Kauhanen; Anni-Maija Linden; Esa R Korpi; Pertti Panula
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

8.  Melanocortin regulation of histaminergic neurons via perifornical lateral hypothalamic melanocortin 4 receptors.

Authors:  Natalie J Michael; Alexandre Caron; Charlotte E Lee; Carlos M Castorena; Syann Lee; Jeffrey M Zigman; Kevin W Williams; Joel K Elmquist
Journal:  Mol Metab       Date:  2020-02-04       Impact factor: 7.422

9.  Cellular taxonomy and spatial organization of the murine ventral posterior hypothalamus.

Authors:  Laura E Mickelsen; William F Flynn; Kristen Springer; Lydia Wilson; Eric J Beltrami; Mohan Bolisetty; Paul Robson; Alexander C Jackson
Journal:  Elife       Date:  2020-10-29       Impact factor: 8.140

10.  Histamine H3 Receptor Function Biases Excitatory Gain in the Nucleus Accumbens.

Authors:  Kevin M Manz; Jennifer C Becker; Carrie A Grueter; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2020-08-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.